Cartilage protective agent (CPA) Ro 32-3555, a new matrix metalloproteinase inhibitor for the treatment of rheumatoid arthritis

Agents and Actions Supplements

Volumn 49, Issue , 1997, Pages 49-55

  Wood, N D ^a   Aitken, M ^a   Durston, S ^a   Harris, S ^a   McClelland, G R ^a   Sharp, S ^a  

^a ROCHE PRODUCTS LTD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CIPEMASTAT; MATRIX METALLOPROTEINASE INHIBITOR; PROTECTIVE AGENT; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; CARTILAGE; CARTILAGE DEGENERATION; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOOD INTAKE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

ADULT; ARTHRITIS, RHEUMATOID; HUMANS; IMIDAZOLES; MALE; METALLOENDOPEPTIDASES; MIDDLE AGED; PROTEASE INHIBITORS;

EID: 0030728087     PISSN: 03790363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (10)